SYSTEMATIC REVIEW
Published on 19 Sep 2025
Comparative gastrointestinal adverse effects of GLP-1 receptor agonists and multi-target analogs in type 2 diabetes: a Bayesian network meta-analysis
doi 10.3389/fphar.2025.1613610
- 1,414 views
- Frontiers in Pharmacology
- Translational Pharmacology
- Research Topics
- Optimizing GLP-1 Receptor Agonist Use: Mechanisms, Clinical Applications, and Safety Profiles
Optimizing GLP-1 Receptor Agonist Use: Mechanisms, Clinical Applications, and Safety Profiles
9,940
Total downloads
47k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 17 Sep 2025
Digital multicriteria evaluation of negotiated medicines using Chinese mini-HTA: application of structured methodologies in assessing once-weekly GLP-1 RAs for improved clinical decision-making
doi 10.3389/fphar.2025.1588056
- 778 views
SYSTEMATIC REVIEW
Published on 26 Aug 2025
Effect of semaglutide on arrhythmic, major cardiovascular, and microvascular outcomes in patients with type 2 diabetes: a systematic review and meta-analysis
doi 10.3389/fendo.2025.1554795
- 1,312 views
REVIEW
Published on 24 Jul 2025
Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact
doi 10.3389/fphar.2025.1618079
- 2,893 views
MINI REVIEW
Published on 30 May 2025
GLP-1R in diabetes mellitus: from basic discovery to therapeutics development
doi 10.3389/fphar.2025.1610512
- 2,307 views
- 1 citation
ORIGINAL RESEARCH
Published on 22 May 2025
Glucagon-like peptide-1, fibroblast growth factor 21, and other endocrine responses to alcohol ingestion in women before and after metabolic surgery
doi 10.3389/fphar.2025.1575156
- 1,794 views
ORIGINAL RESEARCH
Published on 04 Sep 2024
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)
doi 10.3389/fphar.2024.1457363
- 7,131 views
- 3 citations
CLINICAL TRIAL
Published on 22 Aug 2024
Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial
doi 10.3389/fphar.2024.1433587
- 2,430 views
- 3 citations
ORIGINAL RESEARCH
Published on 16 Aug 2024
The GLP-1 receptor agonist exendin-4 reduces taurine and glycine in nucleus accumbens of male rats, an effect tentatively involving the nucleus tractus solitarius
doi 10.3389/fphar.2024.1439203
- 2,576 views
- 4 citations
ORIGINAL RESEARCH
Published on 08 Jul 2024
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
doi 10.3389/fphar.2024.1416985
- 7,643 views
- 14 citations
CASE REPORT
Published on 18 Apr 2024
GLP-1 receptor agonist as an effective treatment for breast cancer-related lymphedema: a case report
doi 10.3389/fonc.2024.1392375
- 12,597 views
- 5 citations
